Effect of biologic lung volume reduction (BLVR) therapy on BODE at 6 and 12 weeks Source: Annual Congress 2008 - COPD Year: 2008
The outcome of patients with COPD selected for a lung volume reduction surgery Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009
Polymeric lung volume reduction (PLVR) therapy for advanced homogeneous emphysema Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy Year: 2010
Responses to polymeric lung volume reduction (PLVR) therapy at 6 months in patients with GOLD stage III emphysema Source: Annual Congress 2010 - Interventions for obstructive lung diseases Year: 2010
CAPTAIN: Effects of lung function at screening (FEV1 % predicted) as a continuous variable on treatment outcomes Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021
Short term change in modified BODE (mBODE) in severe emphysema patients predicts mortality with lung volume reduction surgery (LVRS) Source: Eur Respir J 2006; 28: Suppl. 50, 569s Year: 2006
Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1 Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016
Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy Source: Eur Respir J 2014; 43: 387-396 Year: 2013
Impact of radiological changes on treatment outcome following endoscopic lung volume reduction with coils (LVRC) in patients with advanced emphysema Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018
A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016
Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Single inhaler triple therapy in patients with advanced COPD (FULFIL): exacerbation/pneumonia composite outcomes Source: International Congress 2017 – COPD management Year: 2017
Relationships between baseline quantitative CT densitometry and change in outcome measures following lung volume reduction coil (LVRC) treatment Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy Year: 2010
Effects of helium/oxygen therapy on QoL in lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 455s Year: 2002
Influence of non-medicamentous methods of treatment on heart rate variability (HRV) at patients with bronchial asthma (BA) Source: Eur Respir J 2005; 26: Suppl. 49, 183s Year: 2005
Effect of treatment on conditioning function indices in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 296s Year: 2005
Lung function values as predictors for outcome during non-invasive ventilation in COPD patients Source: Annual Congress 2011 - New evidence in home mechanical ventilation Year: 2011
Impact of long-term oxygen therapy on diaphragm function and pulmonary-cardiac hemodynamics in patients with COPD with hypoxemia (3-year assessment) Source: International Congress 2019 – Lung function and respiratory muscle testing Year: 2019